- Home
- MDIA vs VANI Comparison
MDIA vs VANI Comparison
Compare MDIA & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- VANI
- Stock Information
- Founded
- MDIA 2019
- VANI 1998
- Country
- MDIA United States
- VANI United States
- Employees
- MDIA N/A
- VANI N/A
- Industry
- MDIA Broadcasting
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDIA Consumer Discretionary
- VANI Health Care
- Exchange
- MDIA Nasdaq
- VANI Nasdaq
- Market Cap
- MDIA 61.4M
- VANI 69.9M
- IPO Year
- MDIA N/A
- VANI 2014
- Fundamental
- Price
- MDIA $1.08
- VANI $1.20
- Analyst Decision
- MDIA
- VANI Strong Buy
- Analyst Count
- MDIA 0
- VANI 1
- Target Price
- MDIA N/A
- VANI $3.00
- AVG Volume (30 Days)
- MDIA 312.4K
- VANI 134.7K
- Earning Date
- MDIA 11-14-2024
- VANI 11-13-2024
- Dividend Yield
- MDIA N/A
- VANI N/A
- EPS Growth
- MDIA N/A
- VANI N/A
- EPS
- MDIA N/A
- VANI N/A
- Revenue
- MDIA $69,296,000.00
- VANI N/A
- Revenue This Year
- MDIA N/A
- VANI N/A
- Revenue Next Year
- MDIA N/A
- VANI N/A
- P/E Ratio
- MDIA N/A
- VANI N/A
- Revenue Growth
- MDIA 94.96
- VANI N/A
- 52 Week Low
- MDIA $0.40
- VANI $1.01
- 52 Week High
- MDIA $6.86
- VANI $7.80
- Technical
- Relative Strength Index (RSI)
- MDIA 42.53
- VANI 43.85
- Support Level
- MDIA $1.00
- VANI $1.17
- Resistance Level
- MDIA $1.16
- VANI $1.23
- Average True Range (ATR)
- MDIA 0.12
- VANI 0.05
- MACD
- MDIA -0.00
- VANI 0.00
- Stochastic Oscillator
- MDIA 48.48
- VANI 31.58
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.